Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1001/jama.2020.13319

Type

Journal article

Journal

JAMA

Publication Date

08/2020

Volume

324

Pages

625 - 626

Addresses

Verily Life Sciences (Alphabet), South San Francisco, California.

Keywords

Humans, Registries, United States, Randomized Controlled Trials as Topic, Pragmatic Clinical Trials as Topic, Observational Studies as Topic, Clinical Studies as Topic, COVID-19